New Delhi, Feb. 12 -- Shares of pharma major Lupin rebounded from their day's low after the company posted strong financial results for the quarter ended December 2024 (Q3 FY25). The stock initially fell by 3.2 percent to an intra-day low of Rs.2,000.10 in early trade but later recovered by almost 6 percent, reaching day's high of Rs.2,116.

Lupin reported a consolidated net profit of Rs.858.9 crore for Q3 FY25, marking a 38.8 percent increase from Rs.618.7 crore recorded in the same quarter last year. Revenue for the quarter stood at Rs.5,618.6 crore, reflecting a 10.6 percent rise compared to Rs.5,079.9 crore in Q3 FY24.

EBITDA surged by 32.1 percent year-on-year to Rs.1,409.6 crore from Rs.1,067.3 crore in the previous year. The EBITD...